{"id":2993,"date":"2024-03-30T17:45:07","date_gmt":"2024-03-30T10:45:07","guid":{"rendered":"https:\/\/tppbiotech.com\/?p=2993"},"modified":"2025-05-16T08:26:22","modified_gmt":"2025-05-16T01:26:22","slug":"iso-22716-2007","status":"publish","type":"post","link":"https:\/\/tppbiotech.com\/en\/iso-22716-2007\/","title":{"rendered":"The Importance of ISO 22716:2007 Standard"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t

ISO 22716 is an international standard for cosmetic manufacturing that serves as a key tool in ensuring the quality and safety of cosmetic products. \nCompliance with this standard is required for manufacturers who wish to sell products in the European Union. \nISO 22716 focuses on controlling production processes and product storage to ensure that cosmetics meet established quality and safety criteria. \nAdhering to this standard helps manufacturers improve production quality, expand global business opportunities, \nand enhance the reputation and credibility of their organization and products. In summary, \ncompliance with ISO 22716 builds trust in the brand and ensures products are safe, reliable, and recognized in the market.<\/h4>\n

ISO 22716 establishes principles and processes for effective and safe cosmetic manufacturing according to international standards. \nFollowing this standard gives cosmetic companies confidence in their product quality and builds consumer trust.
\nKey Principles of ISO 22716:\n\nStrict Production Process Control\nAll stages of production are carefully managed, starting with personnel management. \nStaff must be knowledgeable and trained to handle production processes appropriately, with regular evaluations to ensure product quality.<\/h4>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div>
\n\t
\n\t\t\n\t\t
\n\t\t\t
\"\u0e42\u0e23\u0e07\u0e07\u0e32\u0e19\u0e1c\u0e25\u0e34\u0e15\u0e04\u0e23\u0e35\u0e21<\/div>\n\t\t<\/figure>\n\t<\/div>\n<\/div><\/div><\/div><\/div>
\t\t
\n\t\t\t

Equipment and Facility Management\nISO 22716 emphasizes the control and maintenance of equipment, workspaces, and other production facilities. \nEquipment in contact with products must be designed and installed for efficiency and safety. Workplace safety and environmental care are also critical aspects.<\/strong><\/p>\n

Raw Material and Packaging Control\nAll raw materials and packaging components must meet quality and safety standards. \nProduct preparation and packaging processes must follow strict requirements to guarantee safe and high-quality products.<\/strong><\/p>\n

Laboratory Controls\nEffective laboratory procedures are essential, including monitoring and verification of processes, to ensure production complies with established standards.<\/strong><\/p>\n

Management of Outsiders and Risk Mitigation\nISO 22716 includes controls for external personnel, subcontractors, and service providers. \nIt requires risk management and corrective actions for any deviations to maintain consistent quality and safety.<\/strong><\/p>\n

TPP Biotech \u2013 ISO 22716 Certified Cosmetic Manufacturer <\/strong><\/h2>\n

TPP Biotech adheres to ISO 22716 standards to ensure that every step of the production process is monitored for quality and safety. \nThis certification assures clients that cosmetic products and branded goods developed by TPP Biotech are of the highest quality and safe for end consumers.<\/strong><\/p>\n\t\t<\/div>\n\t\t<\/div><\/div><\/div><\/div>

<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"\u0e04\u0e27\u0e32\u0e21\u0e2a\u0e33\u0e04\u0e31\u0e0d\u0e02\u0e2d\u0e07\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19 ISO 22716 \u0e0b\u0e36\u0e48\u0e07\u0e40\u0e1b\u0e47\u0e19\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e01\u0e32\u0e23\u0e1c\u0e25\u0e34\u0e15\u0e2a\u0e33\u0e2b\u0e23\u0e31\u0e1a\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e2a\u0e33\u0e2d\u0e32\u0e07 \u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e19\u0e35\u0e49\u0e40\u0e1b\u0e47\u0e19\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e21\u0e37\u0e2d\u0e2a\u0e33\u0e04\u0e31\u0e0d\u0e43\u0e19\u0e01\u0e32\u0e23\u0e2a\u0e23\u0e49\u0e32\u0e07\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e41\u0e25\u0e30\u0e1b\u0e25\u0e2d\u0e14\u0e20\u0e31\u0e22\u0e02\u0e2d\u0e07\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e2a\u0e33\u0e2d\u0e32\u0e07 \u0e42\u0e14\u0e22\u0e17\u0e35\u0e48\u0e1c\u0e39\u0e49\u0e1c\u0e25\u0e34\u0e15\u0e08\u0e30\u0e15\u0e49\u0e2d\u0e07\u0e1b\u0e0f\u0e34\u0e1a\u0e31\u0e15\u0e34\u0e15\u0e32\u0e21\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e19\u0e35\u0e49\u0e40\u0e21\u0e37\u0e48\u0e2d\u0e1c\u0e25\u0e34\u0e15\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e2a\u0e33\u0e2d\u0e32\u0e07\u0e17\u0e35\u0e48\u0e15\u0e49\u0e2d\u0e07\u0e01\u0e32\u0e23\u0e08\u0e33\u0e2b\u0e19\u0e48\u0e32\u0e22\u0e43\u0e19\u0e2a\u0e2b\u0e20\u0e32\u0e1e\u0e22\u0e38\u0e42\u0e23\u0e1b \u0e0b\u0e36\u0e48\u0e07\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19 ISO 22716 \u0e21\u0e38\u0e48\u0e07\u0e40\u0e19\u0e49\u0e19\u0e44\u0e1b\u0e17\u0e35\u0e48\u0e01\u0e32\u0e23\u0e04\u0e27\u0e1a\u0e04\u0e38\u0e21\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e02\u0e2d\u0e07\u0e01\u0e32\u0e23\u0e1c\u0e25\u0e34\u0e15\u0e41\u0e25\u0e30\u0e01\u0e32\u0e23\u0e08\u0e31\u0e14\u0e40\u0e01\u0e47\u0e1a\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c \u0e40\u0e1e\u0e37\u0e48\u0e2d\u0e43\u0e2b\u0e49\u0e21\u0e31\u0e48\u0e19\u0e43\u0e08\u0e27\u0e48\u0e32\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e2a\u0e33\u0e2d\u0e32\u0e07\u0e21\u0e35\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e41\u0e25\u0e30\u0e1b\u0e25\u0e2d\u0e14\u0e20\u0e31\u0e22\u0e15\u0e32\u0e21\u0e40\u0e01\u0e13\u0e11\u0e4c\u0e17\u0e35\u0e48\u0e01\u0e33\u0e2b\u0e19\u0e14\u0e44\u0e27\u0e49 \u0e01\u0e32\u0e23\u0e1b\u0e0f\u0e34\u0e1a\u0e31\u0e15\u0e34\u0e15\u0e32\u0e21\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e19\u0e35\u0e49\u0e0a\u0e48\u0e27\u0e22\u0e43\u0e2b\u0e49\u0e1c\u0e39\u0e49\u0e1c\u0e25\u0e34\u0e15\u0e2a\u0e32\u0e21\u0e32\u0e23\u0e16\u0e40\u0e1e\u0e34\u0e48\u0e21\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e43\u0e19\u0e01\u0e32\u0e23\u0e1c\u0e25\u0e34\u0e15 \u0e40\u0e1e\u0e34\u0e48\u0e21\u0e42\u0e2d\u0e01\u0e32\u0e2a\u0e17\u0e32\u0e07\u0e01\u0e32\u0e23\u0e04\u0e49\u0e32\u0e17\u0e31\u0e48\u0e27\u0e42\u0e25\u0e01 \u0e41\u0e25\u0e30\u0e2a\u0e23\u0e49\u0e32\u0e07\u0e20\u0e32\u0e1e\u0e25\u0e31\u0e01\u0e29\u0e13\u0e4c\u0e41\u0e25\u0e30\u0e04\u0e27\u0e32\u0e21\u0e40\u0e0a\u0e37\u0e48\u0e2d\u0e43\u0e2b\u0e49\u0e01\u0e31\u0e1a\u0e2d\u0e07\u0e04\u0e4c\u0e01\u0e23\u0e41\u0e25\u0e30\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e02\u0e2d\u0e07\u0e1e\u0e27\u0e01\u0e40\u0e02\u0e32 \u0e42\u0e14\u0e22\u0e2a\u0e23\u0e38\u0e1b\u0e27\u0e48\u0e32\u0e01\u0e32\u0e23\u0e1b\u0e0f\u0e34\u0e1a\u0e31\u0e15\u0e34\u0e15\u0e32\u0e21\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19 ISO 22716 \u0e08\u0e30\u0e0a\u0e48\u0e27\u0e22\u0e2a\u0e23\u0e49\u0e32\u0e07\u0e04\u0e38\u0e13\u0e04\u0e48\u0e32\u0e41\u0e25\u0e30\u0e40\u0e0a\u0e37\u0e48\u0e2d\u0e21\u0e31\u0e48\u0e19\u0e43\u0e19\u0e1c\u0e25\u0e34\u0e15\u0e20\u0e31\u0e13\u0e11\u0e4c\u0e02\u0e2d\u0e07\u0e2d\u0e07\u0e04\u0e4c\u0e01\u0e23\u0e43\u0e2b\u0e49\u0e40\u0e1b\u0e47\u0e19\u0e17\u0e35\u0e48\u0e22\u0e2d\u0e21\u0e23\u0e31\u0e1a\u0e43\u0e19\u0e15\u0e25\u0e32\u0e14\u0e44\u0e14\u0e49\u0e2d\u0e22\u0e48\u0e32\u0e07\u0e21\u0e35\u0e1b\u0e23\u0e30\u0e2a\u0e34\u0e17\u0e18\u0e34\u0e20\u0e32\u0e1e\u0e41\u0e25\u0e30\u0e21\u0e31\u0e48\u0e19\u0e43\u0e08\u0e44\u0e14\u0e49\u0e27\u0e48\u0e32\u0e21\u0e35\u0e04\u0e38\u0e13\u0e20\u0e32\u0e1e\u0e41\u0e25\u0e30\u0e1b\u0e25\u0e2d\u0e14\u0e20\u0e31\u0e22\u0e15\u0e32\u0e21\u0e40\u0e01\u0e13\u0e11\u0e4c\u0e17\u0e35\u0e48\u0e01\u0e33\u0e2b\u0e19\u0e14 ISO22716 \u0e40\u0e1b\u0e47\u0e19\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e17\u0e35\u0e48\u0e01\u0e33\u0e2b\u0e19\u0e14\u0e2b\u0e25\u0e31\u0e01\u0e01\u0e32\u0e23\u0e41\u0e25\u0e30\u0e01\u0e23\u0e30\u0e1a\u0e27\u0e19\u0e01\u0e32\u0e23\u0e17\u0e35\u0e48\u0e40\u0e01\u0e35\u0e48\u0e22\u0e27\u0e02\u0e49\u0e2d\u0e07\u0e01\u0e31\u0e1a\u0e01\u0e32\u0e23\u0e1c\u0e25\u0e34\u0e15\u0e40\u0e04\u0e23\u0e37\u0e48\u0e2d\u0e07\u0e2a\u0e33\u0e2d\u0e32\u0e07\u0e2d\u0e22\u0e48\u0e32\u0e07\u0e21\u0e35\u0e1b\u0e23\u0e30\u0e2a\u0e34\u0e17\u0e18\u0e34\u0e20\u0e32\u0e1e\u0e41\u0e25\u0e30\u0e1b\u0e25\u0e2d\u0e14\u0e20\u0e31\u0e22\u0e15\u0e32\u0e21\u0e21\u0e32\u0e15\u0e23\u0e10\u0e32\u0e19\u0e2a\u0e32\u0e01\u0e25","protected":false},"author":1,"featured_media":2936,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[486],"tags":[485,516,515],"class_list":["post-2993","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-blog","tag-485","tag-516","tag-515"],"_links":{"self":[{"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/posts\/2993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/comments?post=2993"}],"version-history":[{"count":0,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/posts\/2993\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/media\/2936"}],"wp:attachment":[{"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/media?parent=2993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/categories?post=2993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tppbiotech.com\/en\/wp-json\/wp\/v2\/tags?post=2993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}